Establishment of a clinical research database for the analysis of perioperative outcomes in patients with esophageal carcinoma

Establishment of a clinical research database for the analysis of perioperative outcomes in patients with esophageal carcinoma - EsoTrack

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00040116

Enrollment

400

Registered

2026-06-25

Start date

2026-05-08

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C15

Interventions

Group 1: Retrospective analysis of all patients with esophageal carcinoma who underwent oncologic esophageal resection at the University Medical Center Göttingen between January 1, 2020 and March 31,

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: All patients aged = 18 years with esophageal carcinoma who underwent oncologic esophageal resection at the University Medical Center Göttingen between January 1, 2020 and March 31, 2026 will be included.

Exclusion criteria

Exclusion criteria: Patients younger than 18 years and patients who did not undergo oncologic esophageal resection for esophageal carcinoma will be excluded. Cases with insufficient or non-evaluable data will also be excluded.

Design outcomes

Primary

Measure	Time frame
The primary endpoint is the occurrence of a postoperative complication after esophagectomy. Data are collected retrospectively after the patient has been discharged. Routine clinical data are used for this purpose, including information from discharge letters, operative reports, clinical progress notes, imaging findings, endoscopic findings, and other clinical documentation systems. No questionnaires or study-specific scores are used.	—

Measure

Time frame

The primary endpoint is the occurrence of a postoperative complication after esophagectomy. Data are collected retrospectively after the patient has been discharged. Routine clinical data are used for this purpose, including information from discharge letters, operative reports, clinical progress notes, imaging findings, endoscopic findings, and other clinical documentation systems. No questionnaires or study-specific scores are used.

—

Secondary

Measure	Time frame
Secondary endpoints include postoperative mortality, length of hospital stay, overall survival, and oncological outcome after esophagectomy. Postoperative mortality is recorded as death during the inpatient stay as well as death within 30 and 90 days after surgery. Length of hospital stay is defined as the number of days from the date of surgery to discharge. Overall survival is defined as the time from the date of surgery to death from any cause or to the last available follow-up. Oncological outcome includes the occurrence of local recurrence, systemic recurrence, or distant metastases. Data are collected retrospectively using routine clinical data and already existing follow-up data from the tumor documentation system. This includes discharge letters, operative reports, clinical progress notes, histopathological findings, available follow-up information, and data from tumor documentation. No additional patient-reported data collection using questionnaires or study-specific scores is performed.	—

Measure

Time frame

Secondary endpoints include postoperative mortality, length of hospital stay, overall survival, and oncological outcome after esophagectomy. Postoperative mortality is recorded as death during the inpatient stay as well as death within 30 and 90 days after surgery. Length of hospital stay is defined as the number of days from the date of surgery to discharge. Overall survival is defined as the time from the date of surgery to death from any cause or to the last available follow-up. Oncological outcome includes the occurrence of local recurrence, systemic recurrence, or distant metastases. Data are collected retrospectively using routine clinical data and already existing follow-up data from the tumor documentation system. This includes discharge letters, operative reports, clinical progress notes, histopathological findings, available follow-up information, and data from tumor documentation. No additional patient-reported data collection using questionnaires or study-specific scores is performed.

—

Countries

Germany

Contacts

Public ContactDiana Voll

Universitätsmedizin Göttingen

diana.voll1@med.uni-goettingen.de+495513967843

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 10, 2026